These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19715984)

  • 1. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function.
    Renner P; Eggenhofer E; Rosenauer A; Popp FC; Steinmann JF; Slowik P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplant Proc; 2009; 41(6):2607-11. PubMed ID: 19715984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
    Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
    Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.
    Eggenhofer E; Steinmann JF; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    Transpl Immunol; 2011 Apr; 24(3):157-63. PubMed ID: 21194567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
    Poncelet AJ; Vercruysse J; Saliez A; Gianello P
    Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).
    Hoogduijn MJ; Popp FC; Grohnert A; Crop MJ; van Rhijn M; Rowshani AT; Eggenhofer E; Renner P; Reinders ME; Rabelink TJ; van der Laan LJ; Dor FJ; Ijzermans JN; Genever PG; Lange C; Durrbach A; Houtgraaf JH; Christ B; Seifert M; Shagidulin M; Donckier V; Deans R; Ringden O; Perico N; Remuzzi G; Bartholomew A; Schlitt HJ; Weimar W; Baan CC; Dahlke MH;
    Transplantation; 2010 Jul; 90(2):124-6. PubMed ID: 20606604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.
    Li H; Guo ZK; Li XS; Hou CM; Tang PH; Mao N
    Cell Transplant; 2007; 16(1):85-95. PubMed ID: 17436858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial?
    Zonta S; De Martino M; Bedino G; Piotti G; Rampino T; Gregorini M; Frassoni F; Dal Canton A; Dionigi P; Alessiani M
    Transplant Proc; 2010 May; 42(4):1336-40. PubMed ID: 20534295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rodent model of in utero chimeric tolerance induction.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1997 Feb; 16(2):222-30. PubMed ID: 9059934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation.
    Fang L; Lange C; Engel M; Zander AR; Fehse B
    Transplantation; 2006 Nov; 82(10):1370-3. PubMed ID: 17130787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.
    Solari MG; Srinivasan S; Boumaza I; Unadkat J; Harb G; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Mar; 32(2):116-24. PubMed ID: 19217258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.